Paid Clinical Trials New Haven

Discover 1,105 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,105

mRNA-3745A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Farmington CT, Boston MA, Philadelphia PA, Torontoshow 5 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

Ovarian PreservationChoosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

Hartford CT, Commack NY, Harrison NY, Rockville Centre NYshow 4 more

Code:

NCT04569773

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

Impact of Event Scale-Revised

Reproductive Concerns Scale

Decision Regret Scale

MetforminAMPK-activation by Metformin in FSGS: AMP-FSGS

Recruiting

PHASE1

PHASE2

Sponsor:

Yale University

Location:

New Haven CT, New York NY

Code:

NCT06090227

Conditions

Focal Segmental Glomerulosclerosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin + Standard of Care

Placebo + Standard of Care

HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

New Haven CT, New York NY, Pittsburgh PA, Cleveland OHshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

GuselkumabA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Hartford CT, New York NY, Philadelphia PA, Colchester VTshow 3 more

Code:

NCT05923073

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Guselkumab

Observational StudyPulmonary Hypertension Association Registry

Recruiting

Sponsor:

Pulmonary Hypertension Association, Inc.

Location:

Farmington CT, New York NY, Providence RI, Philadelphia PAshow 39 more

Code:

NCT04071327

Conditions

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Hypertension

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

FrexalimabEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Stamford CT, Patchogue NY, Norwich CT, New Brunswick NJshow 80 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

Quemliclustat & ChemotherapyStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting

PHASE3

Sponsor:

Arcus Biosciences, Inc.

Location:

New Haven CT, New Hyde Park NY, New York NY, New Brunswick NJshow 20 more

Code:

NCT06608927

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Quemliclustat

Placebo

Nab-paclitaxel

Gemcitabine

Sacituzumab Tirutecan & PembrolizumabA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

New Haven CT, Stony Brook NY, Stamford CT, Nyack NYshow 26 more

Code:

NCT06312176

Conditions

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Paclitaxel

Nab-paclitaxel

Capecitabine

Hope InterventionSingle Session Intervention to Promote Hope

Recruiting

Sponsor:

Yale University

Location:

New Haven CT

Code:

NCT06375876

Conditions

Domestic Violence

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single-session intervention (SSI)